About: Racial Differences in Time to Treatment for Melanoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Racial Differences in Time to Treatment for Melanoma Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Racial Differences in Time to Treatment for Melanoma
Creator	Archibald, Laura Bordeaux, Jeremy Conic, Rosalynn Mazmudar, Rishabh Rothermel, Luke Scott, Jeffrey Tripathi, Raghav
source	Elsevier; Medline; PMC
abstract	Abstract Background Longer time from diagnosis to definitive surgery (TTDS) is associated with increased melanoma-specific mortality. Although Black patients present with later stage melanoma and have worse survival than non-Hispanic white (NHW) patients, the association between race and TTDS is unknown. Objective To investigate racial differences in time to melanoma treatment. Methods Retrospective review of the National Cancer Database (2004-2015). Multivariable logistic regression was used to evaluate the association of race with TTDS controlling for sociodemographic/disease characteristics. Results Of the 233,982 melanoma patients identified, 1,221 (0.52%) were Black. Black patients had longer TTDS for stage I-III melanoma (p<0.001) and time to immunotherapy (p=0.01), but not for TTDS for stage IV melanoma or time to chemotherapy (p>0.05 for both). Controlling for sociodemographic characteristics, Black patients had over twice the odds of having TTDS between 41-60 days, over three times the odds of having TTDS between 61-90 days, and over five times the odds of having TTDS over 90 days. Racial differences in TTDS persisted within each insurance type. Patients with Medicaid had the longest TTDS (mean 60.4 days), and those with private insurance had the shortest TTDS (mean 44.6 days; p<0.001 for both). Conclusions Targeted approaches to improve TTDS for Black patients are integral in reducing racial disparities in melanoma outcomes.
has issue date	2020-04-08(xsd:dateTime)
bibo:doi	10.1016/j.jaad.2020.03.094
bibo:pmid	32277971
has license	els-covid
sha1sum (hex)	3028e5ac8d6858dd81cf20fae61fbe38a4dc5e37
schema:url	https://doi.org/10.1016/j.jaad.2020.03.094
resource representing a document's title	Racial Differences in Time to Treatment for Melanoma
has PubMed Central identifier	PMC7141633
has PubMed identifier	32277971
schema:publication	J Am Acad Dermatol
resource representing a document's body	covid:3028e5ac8d6858dd81cf20fae61fbe38a4dc5e37#body_text
is schema:about of	named entity 'HAVE' named entity 'THESE' named entity 'INCREASED' named entity 'INSURANCE' named entity 'DIAGNOSIS' named entity 'ASSOCIATED WITH' named entity 'TTDS' named entity 'TIME' named entity 'IMMUNOTHERAPY' named entity 'BLACK' named entity 'time' named entity 'PROOF' named entity 'SPECIFIC' named entity 'TIME' covid:arg/3028e5ac8d6858dd81cf20fae61fbe38a4dc5e37 named entity 'RACIAL DIFFERENCES' named entity 'SOCIODEMOGRAPHIC FACTORS' named entity 'MELANOMA' named entity 'III' named entity 'PRE' named entity 'TREATMENT' named entity 'JOURNAL ' named entity 'PATIENTS' named entity 'MELANOMA' named entity 'DEFINITIVE' named entity 'SURGERY' named entity 'STUDY' named entity 'STAGE I' named entity 'CONTROLLING' named entity 'MORTALITY' named entity '80%' named entity 'Stage' named entity 'immunotherapy' named entity 'factors' named entity 'surgery' named entity 'Longer' named entity 'Racial' named entity 'insurance' named entity 'melanoma' named entity 'melanoma' named entity 'melanoma' named entity 'chemotherapy' named entity 'non-Hispanic white' named entity 'melanoma' named entity 'non-Hispanic white' named entity 'analysis of variance' named entity 'melanoma' named entity 'melanoma' named entity 'AJCC' named entity 'insurance group' named entity 'non-Hispanic white' named entity 'Chi-Square' named entity 'standard deviation' named entity 'univariate' named entity 'melanoma' named entity 'standard deviation' named entity 'melanoma' named entity 'dermatologic' named entity 'Descriptive analyses' named entity 'melanoma' named entity 'NHW' named entity 'poverty rate' named entity 'cutaneous' named entity 'melanoma' named entity 'high-quality' named entity 'melanoma' named entity 'disease-specific' named entity 'immunotherapy' named entity 'melanoma' named entity 'cutaneous' named entity 'melanoma' named entity 'primary tumor' named entity 'Student's t-test' named entity 'cutaneous' named entity 'melanoma'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software